GI and Rheumatology Assessment of Spondyloarthritis in Inflammatory Bowel Disease

Overview

About this study

The objectives of this study are to use a questionnaire to detect Spondyloarthritis (SpA) manifestations will be administered to consecutive patients seen in participating IBD centers with a confirmed diagnosis of IBD, and perform a retrospective chart review to extract clinical data collected as routine standard of care during IBD office visits, including patient demographics, IBD phenotype, disease severity and activity, medication exposures, history of prior rheumatologic diagnoses, and other parameters related to axial and peripheral SpA.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients, ages 18-70 years.
  • Patients with Irritable Bowel Disease (IBD).

Exclusion Criteria:

  • Patients < 18 and over 70 years of age.

Eligibility last updated 5/2/22. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Davis, M.D.

Closed for enrollment

Contact information:

Jane Jaquith C.C.R.C., ACRP

(507) 284-4502

jaquith.jane@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20535090

Mayo Clinic Footer